µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º bN=P*hdf
VS|2|n1<6
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ TJ*T:?>e
]K%!@O!
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) 'we>q@
/wlEe>i
1. ICAM-1 LXCx~;{\
{Hk}Kow
2. interleukin 12(IL-12)
W!(LF7_!
tZB<on<.)
3. tumor infiltrating lymphocyte hFBe,'3M
Vf1^4t
4. TCR/CD3 complex N4HqLh
23H
Z$? #
5. hematopoietin receptor family 2b8L\$1q
(C)p9-,
6. individual idiotype(IdI) f|oh.z_R
Ssg&QI
7. integrin 9-m=*|p
caX<
n>
8. colony-stimulatory factor (CSF) Z<{QaY$"
5Jnlz@P9
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© I1&aM}y{G
{BU;$
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? ( &x['IR
g<
.qUBPKX
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ "-V"=t'
h2J
x]FJ
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ^T-V^^#(
KJZ4AWH`
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ A\5L
7
@pU)_d!pJ
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) _v]MsT-q
0#^v{DC
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ Aq7osU1B
0_t!T'jr7
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) SByW[JE
H}
g{Cr"Ex
3. immunoglobulin superfamily (IgSF) ;sFF+^~L
4H]L~^CD
4. selectin jrh43
\$*
$* Kvc$D
5. anti-idiotypic antibody (¦ÁId) wq `Bd
:*\P n!r
6. major histocompatibility complex(MHC)
3?
+Hd
'2^Q1{ :\
7. immunotolerance :9 ^*
^T
Q]>.b%s[
8. biological reponse modifier(BRM) pyvSwD5t
?6Y?a2 |
9. immune reponse gene (Ir gene) a:6m7U)P#5
wD)XjX
10. reshaped antibody (or reconstituted antibody) MFk5K
o"#\
>
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ~/P[J
wAW5
Z0D
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ %bfQ$a:
S^ \Vgi(
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? W6/
yn
:20W\P<O!A
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ 3/n5#&c\4
JFk
lUgg
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? u4h4.NHX
~IN>3\j
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ JcxThZP~
y_lU=(%Jd
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? E=!\z%4
j eP
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ %OOl'o"V{s
j#q-^h3H
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ ;hN!s`vq
G*P#]eO
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨?
7E~;xn;
Z}Ft:7
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ^,T(mKS
:! !at:>
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: bB3powy9
:^B1~p(?sK
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ZX./P
0
]|PiF+
̉񧄤 n]o<S+z
x-&@wMqkc
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© lp%pbx43s
H]Z$OpI
1. CD8 x)O!["'"
>jc [nk
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) 0{}8(
K/yxE|w<
3. immunoglobulin fold(Ig fold) ]Ntmy;Q
=R$u[~Xl2X
4. cadherin (Ca-dependent cell adhesion moleculers) VY=jc~c]v
dn$!&
5. idiotype-anti-idiotypic antibody immune network theory PmEsN&YP]
0rs"o-s<
6. HLA class II antigen 8\A#CQ5b
!9VY|&fHe
7. complementarity-determining region (CDR) 1JG'%8}#8
~YWQ2]
8. perforin(or pore-forming protein ,PFP) y'nK>)WG4
u[=r,^YQ
9. high affinity IL-2 receptor ShP^A"Do
Zaf:fsj>
10. artificial active immunization aP@N)"
2E)-M9ds
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© fW1CFRHH
U}rU~3N
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ,~@X{7U
SBk4_J/_
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 6@F9G4<Z
dhf!o0'1M
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ BLf>_bUk
g63(E,;;J
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ _P 3G
SaAFz&WRl
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ s %``H`
0#s"e}@v
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? /1V xc 6
o!Ieb
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ l<LP&
r|fL&dtr
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ _~J
{wM
^?7-r6
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ Kp~VS<3
rv^@, 8vq
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ P%:wAYz1^O
HU8900k+
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© p{Yv3dNl
Vvn2 Ep
1. immunoglobulin gene rearrangement ll<Xz((o
t?x<g <PJ4
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) r6MMCJ|G
7uS~MW
3. flow cytometry(FCM) 7Oa#c<2]
QQ*hCyw!
4. carrier effect 6xe*E[#k\
QT<
}]
0
5. positive selection of T lymphocytes in thymus Q_Q''j(r6b
6Z6'}BDP
6. mouse TH1(Th1) and TH2(Th2) subsets @fZ,.2ar
(
iBl
7. perforin (pore-forming protein ,PFP) av}k)ZT_
U8s2|G;K
8. ADCC(antibody-dependent cell-mediated cytotoxicity) fIx+ILs
a+[KI
9. SH-2(src-homology region 2) <.x{|p
aD<A.Lhy
10. Ab2¦Â (internal image) y2Q&s9$Do
mDA:nx%5<
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© #`qx<y*S
2RVN\?s:
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? WrnrFz
/QK6Rac-
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? gDQ^)1k
MD}w Y><C
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠwjU9ZGM
DzAg"6=CS
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ AVsDt2A
2jA {SY-
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠn2"a{Ofhlf
+C^nO=[E
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) w1FcB$
prUN)r@U
ÃâÒßѧרҵ£º #>a\>iKQ2q
vOH4#
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ y B81f
]
7[
3>IN
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? /m!BY}4W
Zcey|m*|
´«È¾²¡Ñ§×¨Òµ£º .y'
>[
WSPI|#Xr%
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ j}#w)M
Ky`qskvu
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ w$>u b@=
]HbY
Ïû»¯×¨Òµ£º HRpte=`q
Q*GN`07@?d
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ QDZWX`qw{
Q@= Q0
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? M.JA.I@XC
l&
[O
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ
)| ccX
xKbXt;l2
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 4a&RYx
V( }:=eK
1. Fas(CD95)/FasL pt?bWyKG
A]*}HZ,
2. common chain of cytokine receptor z>xmRs
}f%} v
3 . TCR/CD3 complex aNsBcov3O
5;
C|
4. negaive selection of thymocytes :x3QRF
_r#Z}HK
5. artificial active immune H;mSkRD3N
TT%M'5&
6. anti-idiotypic e
v}S+!|U
RIR\']WN
7. IgSF BX/8O<s0
`b&%Hm
8. Integrin i%iL[id:w
xa'*P=<)C'
9. chemokine xh-o}8*n"
/A\8 mL8
10. B7/CD28 Ng
&%
o
+bxYGD
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© >dXGee>'M
rw[ph[\X
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ (y'hyJo
sfH_5
#w
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ D>r&}6<
Rr$-tYy6
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ G&SB-
~%F9%=
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ .~db4d]
jwe *(k]z
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ %QH$ipM
yF:1( 4
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ t,Lrfv])
G5_=H,Vmd
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© D8Ic?:iX[
r r %V.r;2
1. B7/CD28 ^6x
%*/l|
A QU+mo
2. Th1 subset KkyVSoD\
unzr0x
{
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© M^Yh|%M
,,.QfUj/&
4. antibody affinity maturation YqD=>P[O
I|!OY`ko
5. AP-1 c]-<vkpV
5I;&mW`1,`
6. single chain variable fragment£¨ScFv£© N% B>M7-=
Paq4
7. NK cell receptor @;4zrzQi7
nPtuTySG
8. Zinkernagel-Doherty phenomenon qwcD`HV,
3*bU6$|5FP
9. Ig fold By,eETU]
iyE7V_O T
10. CD40/CD40L
X
JB)rP
59L\|OR
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© cZ*@$%_
@4C% +-
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ Oszj$C(jF
"{xrL4BtC
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ D)P ._?
1.hyCTnI
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ G4;Oi=
Qel9G($=
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ `(;m?<%
2pCaX\t
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ Ne!lH@ql
?z+eWL
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ Gz0]}]A
`}\
"Aw c
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ >'$Mp <
RB\uK
1+
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ~ Iuf}D;
NxY#NaE:?4
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© f~[7t:WD*
@HC Vmg:
1.Co-stimulators (or co-stimulating molecules) [|L<_.8
]W!0$'o
2.NK-kB vr l-$ii
}.(B}/$u
3.Immunoglobulin superfamily $%Kfq[Q
:Yl-w-oe
4.antigen-presenting cell (APC) 3d]S!=4H"
x,-75
5.death domain t{kG<J/l
F>l]
9!P|m
6.CCR and CXCR d0ksG$
SH$PwJ U
7.Lectin (or mitogen) A/s?x>QA
=T@1@w
8.Clusters of differentiation, CD) * u>\57W
KpGhQdR#
9.B7 family tWRC$
4HlQ&2O%#
10.Cytotoxic T lymphocyte, CTL) D@.6>:;il
o*
H<K
aX
11.IL-15 and IL-15 receptor (IL-15R) cwg"c4V
D,feF9
12.MHC restriction wHy!CP
%
&QgR*,5eo
13.Affinity-chromatography }7Q% 6&IR
y)@wjH{6
14.Cyctosprin A, CsA o+'6`g'8
(<9u-HF#
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) [W&T(%(W-
?@86P|19
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© g7H(PF?
M= (u]%\
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 $UwCMPs X
2^7`mES
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ <hyKu
a7opCmL
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ C U0YIL
W>r+h
-kR
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Pq$n5fZC!
e0 ecD3
ÃâÒßѧרҵ£º p_4<6{KEt
:3 mh@[V
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ ]SE
ZaT
u ga_T
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ;'1d1\wiDQ
u3D)M%e
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ h68 xet;
(9)Q ' 'S
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) 3so%gvY.'
WIGi51yC.x
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) =_^X3z0
pj(,Zd[47
1. ADCC(antibody dependent cell-mediated cytotoxicity) W,u:gzmhw
zuCSj~
2. »·æß¾úËØ(cyclosporin) W g!
Lfu
<VE@DBWyl~
3. KIR(killer cell inhibitory receptor) pR_9NfV{
Bw
yx
c
4. HLDA(human leucocyte differentiation antigen) $cgcX
6\t@)=C,Q
5. Interleukin 18(IL-18) wC*X4 '
lquLT6]
6. ÕûºÏËØ(integrin) jiGTA:v
gM]:Ma
7. Fas/FasL c@Is2
9t*
xD 7]C|8o
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) kx CSs7J/
:11
A
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) 3g
B7g'U
)%]J>&/0J
10. Th1/Th2 x1<|hTPk
~M$Wd2Th
11. »ùÒòÒßÃç(DNAÒßÃç) so
s5Y}
ykJ>*z
12. chemokines and chemokine receptor u@^LW<eD
wM{s|Ay
13. ÃâÒßÄÍÊÜ DfB7*+x{
VaPG-n>Vf
14. ¹²´Ì¼¤·Ö×Ó =lSNs
w(F%^o\
15. ËÀÍö½á¹¹Óò(death domain) ipz5 H*
}a/Cro.~4
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) 0 {mex4
('~LMu_
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? [ hsds\
:KO2| v\
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠJS77M-Ac
?ubro0F:
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î AwN!;t_0+N
]^]wP]R_
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ u:EiwRW
M=Wz
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå jdBLsy@
"#48% -'x
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ Dh*n!7lD`
@PU [:;
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) 0$njMnB2l
Js;h%
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ pJ{Y
lS{
D,6:EV"sa
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ 7o4\oRGV
m kexc~l
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£